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I.  Enhancement of Antibody Formation in Mice* 
BY PANG  N. SHEK$  AND ALBERT  H. COONS§ 
(From the  Department of  Pathology, Harvard Medical School, Boston, Massachusetts 02115) 
In 1954, some experiments were carried out in this laboratory on the effect ofcolchicine 
(CC) 1 on  antibody formation  in  rabbits.  At that  time,  we  had  found  that  antibody 
formation was associated with rapid and extensive cell divisions in the plasma cell  and 
its immediate precursors which had just been associated with antibody synthesis (1). We 
thought,  therefore,  that  the  injection  of CC  would  inhibit  antibody  formation,  and 
Tanaka and Coons carried out some experiments to investigate this proposition. Much to 
our surprise, CC enhanced the antibody response in rabbits by a factor of --- 8. The results 
of these experiments are simple to relate.  We administered antigen to naive or primed 
rabbits  with or without CC,  and measured the  antibody response in the serum.  The 
enhancing effect was found to depend on the administration of CC on the same day as 
the antigen. It was ineffective when given 2 days before or 2 days after the injection of 
antigen. Indeed, it had a slightly depressive effect when given 2 days after the antigen, 
and an even greater effect when given on day 4 after antigen administration. But given 
simultaneously with the antigen,  it had an increasingly pronounced effect as the dose 
was increased from 0.5 to 2 mg/kg. The latter dose killed three of the four rabbits tested, 
but the survivor had an antibody titer on the 8th day of his response 50 times higher 
than the control rabbits which received no CC.  These facts in the rabbit were true for 
both the primary and secondary antibody response.  At that time, we were at a  loss to 
explain these findings and published them only in an abbreviated form (2, 3). 
When Gershon discovered the existence of the suppressor cell  in 1970 (4), it seemed 
possible that the effect of CC could be explained by the elimination of some or all of the 
suppressor cells which are evidently stimulated to arise during every antibody response. 
It  is  noteworthy  that  in  1952, Taliaferro  et  al.  (5)  investigated  the  effect  of X- 
irradiation (total body radiation with 600 or 700 rods) on hemolysin production against 
sheep erythrocytes in the rabbit.  They found that peak titers were reached when the 
antigen was administered from 6 h to 10 min before irradiation took place. 10 years later, 
Dixon and McConahey (6) also investigated the effects of whole body radiation on the 
antibody response to bovine gammaglobulin in the  rabbit.  They found that the  peak 
antibody titer to a primary stimulus was about four times that of the control value and 
appeared when the irradiation was carried out 2.5 days aider  the injection of antigen, 
although there was also a smaller elevation when the irradiation was carried out 1 day 
after an antigen injection. 
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Fourfold  enhancement  of  diphtheria  antitoxin  in  guinea  pigs  was  described  by 
Greenberg and Fleming (7) when pertussis vaccine was injected subcutaneously at the 
same time. Johnson et al.  (8) described the enhancement of antibedy formation to protein 
antigens by the injection of endotoxin from bacterial cell wall. 
In 1963, White (9) published a review entitled ~Factors affecting the antibody response" 
in  which  he  described  some  unpublished  data  (Farthing  and  White,  1959) which 
demonstrated the enhancing effect of CC (1 mg/kg) on both the primary and secondary 
response of guinea pigs to diphtheria toxoid.  They reported about a 10-fold difference in 
both primary and secondary responses when CC was administered 6 h before or 6 h after 
the antigen. 
In 1976, Bash, Singer, and Waksman (10) reported that cyclophosphamide (20-50 rag/ 
kg) given on the day of antigen injection to donor rats abrogated the suppressive effect on 
recipients of the T-cell  fraction of rat spleen cells.  Finally,  Burchiel and Melmon (11) 
reported  that  the  mitotic  inhibitors,  CC,  cytosine  arabinoside,  and  hydroxyurea,  all 
produced dose-dependent augmentation of the antibody response in cultures of murine 
spleen cells. 
These findings clearly predict the existence of a suppressor cell since both X-ray and 
CC were known to kill dividing cells.  The effect of endotoxin is not so clear, but perhaps 
it interferes with cell division at a critical moment. 
In view of our early findings with CC and the effects of X-ray and endotoxin, 
we decided to test the working hypothesis that these materials killed suppressor 
cells.  To  do this,  it  was  necessary to  carry out  experiments  with  animals  in 
which  cell  transfers  could  be  carried  out,  namely  inbred  mice.  This  paper 
describes the conditions required for the effective enhancement of the antibody 
response by CC in mice.  Our results indicate that CC is effective in promoting 
the  antibody response  of mice to protein  antigens,  e.g.  diphtheria toxoid and 
human gamma globulin, as well as to a hapten, 2,4,6-trinitrophenyl (TNP). For 
maximal enhancement, the drug must be administered simultaneously with the 
antigen.  In an accompanying paper,  we shall  present evidence which demon- 
strates the action of CC on suppressor cells. 
Materials  and  Methods 
Animals.  Male or female BALB/c mice, 8- to  16-wk-old, were obtained  from The Jackson 
Laboratory, Bar Harbor, Maine; from Charles River Breeding Laboratories, Wilmington, Mass.; 
or from the West Seneca Laboratory, Health  Research Inc., West Seneca, N. Y. Animals were 
maintained  in cages with free access to laboratory mouse chow and acidified, chlorinated water. 
Antigens and Immunization.  Purified diphtheria  toxoid (DT) and  human gamma  globulin 
(HGG) were supplied by the Massachusetts  Department  of Public Health,  Division of Biologic 
Laboratories, Boston, Mass. The hapten-carrier  conjugate, trinitrophenyl-keyhole  limpet hemo- 
cyanin (TNP-KLH), was prepared from 2,4,6-trinitrobonzene sulfonic acid (Eastman  Kodak Co., 
Rochester, N. Y.) and KLH (Calbiochem, San Diego, Calif.) according to the procedure described 
by Rittenberg and Amkraut (12). The conjugate used in the present study had a ratio of 762 tool of 
TNP/mol of KLH. In some experiments,  TNP-KLH was absorbed on bentonite  particles by the 
method of Gallily and Garvey (13) for the purpose of immunization.  All mice were immunized 
intraperitoneally.  The doses of antigens  used for immunization  are  specified in the text.  CC 
(Sigma Chemical Co., St. Louis, Mo.) in physiological saline was administered intraperitoneally 
to appropriate groups of animals at doses ranging from 0.25 to 1.5 mg/kg body weight, depending 
upon the experimental protocol. 
Passive Hemagglutination.  Mice  were bled from the ophthalmic venous plexus and the sara 
obtained were inactivated at 56°C for 30 min. Circulating antibody levels were measured by the 
hemagglutination  of sheep erythrocytes,  (SRBC; Colorado Serum Co., Denver, Colo.) covalently 
coupled to the protein antigen  by bis-diazobenzidine according to the method of Stavitsky  and 
Arquilla (14). For the detection of hapten-specific antibodies, the indicator SRBC were coupled to PANG  N.  SHEK  AND  ALBERT  H.  COONS  1215 
TNP as described by Rittenberg and Pratt {15). Antibody titers were expressed as the reciprocal of 
the highest serum dilution which gave positive hemagglutinating reactions. 
Preparation of Cell Suspensions  and Hemolytic Plaque Assay.  Mice were sacrificed by cervical 
dislocation.  The spleens were harvested and gently teased with sharp forceps in balanced salt 
solution (BSS;  16).  The dispersed spleen cells were filtered through stainless steel screens and 
were washed three times in BSS by centrifugation at 1,000 rpm for 10 min each time. The washed 
spleen  cells  were  assayed  for  antibody-forming cells  by  a  modified  method  (16)  of the Jerne 
hemolytic plaque technique (17).  Indicator SRBC were prepared according to the method of Kapp 
and Ingraham (18) for HGG-SRBC and of Rittenberg and Pratt (15) for TNP-SRBC.  Briefly, the 
assay  of plaque-forming  cells  was  performed  as  follows.  Glass  culture  tubes  (10  ×  75  ram) 
containing 0.3 ml of 0.7% agarose (L'Industrie Biologique Francaise S. A., Gennevilliers, France) 
in BSS,  50  Izl of HGG-SRBC  (7.5%)  and 20  ~l of SRBC-absorbed 0.5%  bovine serum  albumin 
solution were preincubated in a 41-42°C water-bath. 50 Izl of a  spleen cell suspension containing 
105-10 ~ viable nucleated cells were added to each tube.  The mixture was gently but thoroughly 
mixed and was then spread on a microscope glass slide previously coated with 0.1% agarose. After 
the agarose had solidified, the slides were inverted, placed on plexiglass trays and incubated at 
37°C  in  a  humidified chamber.  After a~  incubation period of 1.5-2.0  h,  freshly  reconstituted 
guinea pig complement (Pel-Freez Farms, Inc., Rogers, Ark.), at 1:15 dilution, was flooded under 
the slides. After an additional 1.5 h incubation, the number of plaque-forming cells (PFC) on each 
slide  was  enumerated  under  a  low-power  microscope.  For  the  development  of  IgG  PFC,  a 
previously determined optimal dilution of a  polyvalent rabbit anti-mouse IgG antiserum (kindly 
supplied  by  Dr.  Carl  W.  Pierce  of the  Jewish  Hospital  of St.  Louis,  St.  Louis,  Mo.)  was  in- 
corporated in the agarose mixture.  The number of IgG PFC was calculated from the difference 
between  the  number of IgM  PFC  and  the  total  number of PFC  developed  with  the  anti-IgG 
antiserum. 
Preparation  of Lumicolchicine.  Lumicolchicine  was  prepared  by  the  irradiation  of  a  CC 
solution in a  quartz cuvet placed at 12 inches from a  UV lamp (Osram High Pressure Mercury 
Arc, HBO 200; Osram, Munich, W. Germany) for 30 min. The successful conversion of CC to pre- 
dominantly beta- and gamma-lumicolchicines was monitored by the appearance of two isosbestic 
points at 255 and 305 nm in their UV spectra, and by a  decrease of absorbancy at 350 nm (19). 
Results 
Primary Antibody Response.  Mice injected intraperitoneally with 100 ~g of 
TNP-KLH-bentonite  (TKB)  on  day  0  gave  a  peak  hapten-specific  IgM  PFC 
response on days 6 and 7 (Fig.  1 A). The simultaneous administration  of CC (1 
mg/kg body weight) with 100 ~g of TKB to animals in the experimental group 
increased the IgM PFC response by about twofold. The hapten-specific IgC PFC 
response of CC-treated animals  was also greater than that  of control animals 
(Fig. 1 B). Significant elevation in the circulating anti-TNP antibody titers was 
observed  in  immunized  animals  treated  with  CC  (Fig.  2).  The  enhanced 
antibody  level  appeared  as  early  as  7  days  after  immunization,  and  the 
difference in antibody titer between the two groups lasted for at least 14 days. 
The administration  of CC to animals  immunized  with HGG also significantly 
(P  <  .001)  enhanced  the serum  antibody titer at  1 wk,  but not 4 days,  after 
immunization  (Fig.  3).  DT was found to be a  relatively poor antigen  for the 
induction of a  primary response in mice even when CC was given. 
Secondary Antibody Response.  The  immunization  of mice with two injec- 
tions of DT  (20 Lf per injection)  20 days apart,  gave a  consistent response in 
terms of the mean circulating antibody titer I0 days after the second injection of 
antigen (Fig. 4). When colchicine was also administered to similarly immunized 
animals at the time of priming (group II), at the time of challenge (group III), or 
at both times  (group IV),  the subsequent antibody response was increased by 
about  15-fold.  The  kinetics  of the secondary response in  mice which received 1216  ENHANCEMENT  OF  THE  ANTIBODY  RESPONSE  BY  COLCHICINE 
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Fro.  1.  Effect of CC on the kinetics of the TNP-spocific  primary PFC response.  BALB/c 
mice were immunized intraperitoneally with 100 ~g of TKB (©) or with 100/~g of TKB and 
CC  (1  mg/kg,  Q);  their  spleens  were  harvested  for  PFC  assay  at  various  times  after 
immunization. Each point represents the mean -+ SE of the response of 4-16 animals. SC, 
spleen cells. 
two injections  of DT  and  CC  showed that the enhanced  response occurred as 
early  as  5  days  after  the  second  immunization  (Fig.  5).  The  difference  in 
antibody titers between CC-treated animals and control animals lasted for more 
than 15 days. The effective CC dose for maximal enhancement was between 1.0- 
1.5  mg/kg body weight  (Fig.  6).  The  drug was found to be  lethal  to  injected 
animals  at doses above 1.5  mg/kg and the mean  lethal  dose  (LDso)  of CC for 
BALB/c mice was 2.1 mg]kg (Fig. 7). Since a relatively large amount of purified 
DT  would  have  been  needed  for  the  sensitization  of  indicator  SRBC  in  a 
hemolytic plaque assay,  the number of DT-specific antibody-forming cells was 
not  enumerated.  Instead,  the  effect  of CC  on  the  PFC  response  to  another 
protein antigen  (HGG),  and to a hapten  (TNP) was studied. 
Mice  previously  primed  with  HGG  and  challenged  10  days  later  with  the 
same antigen gave a relatively low HGG-specific IgG PFC response (Fig.  8 A). 
On the  other hand,  similarly  immunized  animals  which were  also  given  CC e,- 
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FIG. 2.  CC-induced enhancement of  serum anti-TNP hemagglutinating antibody levels. 
Mice were injected  intraperitoneally  with 100 ~g of  TKB ([=-'~  or  with 100 ~g  of  TKB and 
CC (1 mg/kg,  ~).  Animals were bled on days 7, 10, and 14 after  the injection.  Each bar 
represents  the mean titer  -+SE of  6-7 animals. 
showed an IgG PFC response which was about three times as large.  Since very 
few, if any IgM PFC were detected by this system (20),  we could only express 
our HGG-specific PFC  response  by the  number of indirect  plaques  obtained. 
The  increase  in  the  number  of antibody-forming  cells  was  accompanied  by 
elevated circulating antibody levels which persisted for a  longer period of time 
(Fig.  8 B).  In the case of the secondary PFC response to the TNP hapten,  the 
administration of CC to experimental animals at the time of priming enhanced 
both the IgM and the IgG response (Fig.  9). The IgM PFC response of the CC- 
treated  animals was twice as large  (Fig.  9 A),  and the IgC PFC response was 
about four times as large as that of the control animals  (Fig. 9 B). 
Relationship between  the Time of Administration of CC and the Enhance- 
ment of the Antibody Response.  Different groups of animals were given CC at 
times before (day -1), during (day 0), or after (day + 1 and day +2) the injection 
of TNP-KLH.  Animals  in  the  control  groups were injected with the  antigen 
alone.  The primed animals were challenged with TNP-KLH on day 14. 3 days 
after the second injection, the spleens of the immunized animals were assayed 
for their secondary hapten-specific PFC response. Maximal enhancement of the 
PFC response was observed when CC was administered to animals on the same 
day as the injection of antigen (Fig. 10 A). Although minimal enhancement was 
observed when the drug was given to animals  1 day before immunization,  no 
elevation in the PFC response was noted when the drug was administered  to 
animals  1 or 2 days after immunization.  Similar results were observed in the 
primary response; the drug was most effective when given to animals  on the 
same day as antigen  injection (Fig.  10 B). 1218  ENHANCEMENT  OF  THE  ANTIBODY  RESPONSE  BY  COLCHICINE 
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FIO. 3.  Effect  of CC on the circulating anti-HGG antibody  titers. Mice were injected 
intraperitoneally with 100 ~g of HGG  (F-'3)  or with 100 /~g of HGG  and CC (1 mg/kg, 
l).  Each bar represents the mean titer  ±  SE of 6 animals bled on day 4, and of 13 
animals bled on day 7. n.s.,  not significant. 
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FIG.  4.  CC-mediated enhancement of  the secondary antibody response of  mice immunized 
with DT. Control animals in group I were primed with 20 Lf of DT on day  -20 and 
challenged with a similar dose of antigen on day 0. Animals in the experimental groups 
were immunized in  a similar  fashion except that CC, at  a dose of  I  mg/kg body weight, was 
also  administered at the time of  priming (group If),  at  the time of  challenge (group III),  or 
at  both times (group IV).  All animals were bled 10  days after  the second injection.  Each bar 
represents the mean titer  ± SE of  8 animals. PANG  N.  SHEK  AND  ALBERT  H.  COONS  1219 
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FIG.  5.  Effect of CC on the kinetics of the secondary response to DT. Control animals (Q) 
were given two  intraporitoneal injections of 20 Lf of DT 20 days  apart.  Animals in the 
experimental group (@) were similarly immunized except that CC, at a  dose of 1.5 mg/kg, 
was also administered at the time of antigen injection.  Each point represents the mean 
titer _+ SE of 7-8 animals. 
W 
b- 
g 
m 
I.-  I0 
z 
g 
0 
J 
lSi-- 
,  ,  ,  I  ,  ,  ,  I  ,  ,  ,  I 
O  0"5  I'D  1.5 
m~ COLCHIGINE/kg  BODY WEIGHT 
FIG.  6.  Titration  curve  of the  effect  of different  doses  of CC  on  antibody  formation. 
Control  mice  were  given  two  intraperitoneal  injections of 20  Lf of DT  20  days  apart. 
Animals in the experimental groups were similarly immunized except that CC, at various 
doses as indicated in the abscissa, was also given. All animals were bled 10 days after the 
second injection, and their serum anti-DT hemagglutinating antibody titers were deter- 
mined. Each point represents the mean titer _+ SE of 5 animals. 1220  ENHANCEMENT  OF  THE  ANTIBODY  RESPONSE  BY  COLCHICINE 
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FIG.  7.  Determination of the LDso of CC in mice. BALB/c mice (10 animals/group) were 
injected  intraperitoneally  with  various  doses  of CC  ranging  from  0  to  3.0  mg/kg body 
weight'. Each point represents the percent of animals which survived for at least 10 days 
after CC injection. 
Comparison of the Effect of Two Different Anti-Mitotic Drugs on the Antibody 
Response.  Vinblastine  (VB),  another  anti-mitotic  drug,  was  tested  for  its 
effectiveness in enhancing the antibody response. Three groups of animals were 
similarly immunized with TKB. Animals in group II also received CC (1 mg/kg) 
and those in group III were injected with a  similar dose of VB on the day of 
immunization.  6 days later, the spleens of the treated animals were assayed for 
their hapten-specific PFC response.  Results shown in Table I indicate that VB 
was as effective as CC in enhancing the anti-TNP PFC response. 
Effect of Lumicolchicine  on the Antibody Response.  Lumicolchicine (LCC), 
the structural isomer of CC, was tested for its effectiveness to enhance antibody 
formation.  Mice in the control group were injected intraperitoneally  with 100 
ttg of TKB on day 0. Two other groups of animals were immunized in a similar 
manner,  except that CC was also administered to I group and LCC to the other. 
The dose given in each case was I mg/kg body weight. The hapten-specific PFC 
response was assayed on day 6. Results shown in Table II indicate that whereas 
CC enhanced the TNP-specific PFC response by more than 100%, the adminis- 
tration of LCC to immunized animals had no enhancing effect. 
Discussion 
Results of experiments performed in mice and reported in the present paper 
confirm the original observations by Tanaka and Coons (2) that CC is effective 
in enhancing the antibody response. Apparently, there is no species difference 
in terms of the capacity of CC to promote antibody formation  since the drug 
works well in  rabbits  (2,  3),  guinea  pigs  (9),  hamsters  (21),  and  in  mice  as 
presently reported. 
Previous reports on CC-induced enhancement expressed the enhancing effect 
only in terms of the serum antibody level, and the magnitude of the maximal 
enhancement  varied from 3- to 50-fold (2, 9, 21,  22).  In the present study with PANG  N.  SHEK  AND  ALBERT  H.  COONS  1221 
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Fro.  8.  Enhancement of the secondary  antibody response  to HGG by CC.  Mice in the 
control group (©) wez:e given 2 intraperitoneal injections of 100 ~g of HGG 14 days apart. 
Animals in the experimental group (e) were similarly immunized except CC, at a dose of 1 
mg/kg, was also administered at the time of antigen injection. At various times after the 
second injection, the animals were bled for the determination of serum hemagglutinating 
anti-HGG antibody titers (B) and their spleens were harvested for the assessment of their 
PFC response (A). Each point represents the mean response  +- SE of 4-10 animals. SC, 
spleen cells. 
mice,  our  data  indicate  that  CC-induced  enhancement  of  the  circulating 
antibody titer varied from as low as 3-fold  (in the primary response to HGG, 
Fig. 3) to as high as about 15-fold (in the secondary response to DT, Fig. 4) more 
than  that  of the  control  group.  In addition  to  evaluating the  serum antibody 
titer,  this  study  also examined  the  cellular  aspect through  the  assessment of 
the PFC response. The data indicate that the number of antibody-forming cells 
in the spleens of CC-treated animals was significantly increased.  For example, 
the  hapten-specific  primary  PFC  response  was  doubled  (Fig.  1)  and  the 
secondary IgG PFC response was enhanced by at least fivefold (Fig.  9).  In the 
case of the secondary PFC response to HGG, the response of CC-treated animals 
was  at  least  three  times  as  large  as that  of control  animals  (Fig.  8 A).  This 1222  ENHANCEMENT  OF  THE  ANTIBODY  RESPONSE  BY  COLCHICINE 
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FIG. 9.  Effect of CC on the secondary  TNP-specific  PFC response.  Mice in the control 
group  (©) were given 2 intraperitoneal injections  of 100 ~g of TNP-KLH  14 days apart. 
Animals in the experimental group (Q) were similarly immunized except CC, at a dose of 1 
mg/kg, was also given at the time of priming.  On each day between 2 and 6 days after 
challenge, spleens of the immunized animals were harvested for the assay of their hapten- 
specific PFC response.  Each point represents the mean response _+ SE of five animals. SC, 
spleen cells. 
increase  in the  PFC  response  was accompanied  by  an elevation  of the  serum 
antibody titer (Fig.  8 B). These results implied that the administration of CC at 
the time of antigenic  penetration  affected certain cellular events leading to an 
increase  in the number of antibody-forming  cells  which in turn  increased  the 
circulating antibody level. 
For effective enhancement of the antibody response by CC, there are at least 
two critical factors which have to be observed;  (a) the dose of CC used,  and (b) 
the time of its administration. 
Within the dose range that is not lethal for mice, maximal enhancement may 
be  obtained  by  the  injection  of  1.0-1.5  mg  CC/kg  body  weight  (Fig.  6).  An 
increasingly pronounced enhancing effect was also observed in the rabbit when 
the dose of CC was increased from 0.5 to 2.0 mg/kg  (2).  It is of interest to note 
that despite the tremendous difference in susceptibility to the lethal effect of CC 
between mice  (LDso 2.1  mg/kg;  Fig.  7) and hamsters  (LD~o 300 mg/kg;  Ref.  22) 
the optimal  dose of CC  for the enhancement of antibody  formation lies within 
the same range of about 1.0-1.5  mg/kg. PANG  N.  SHEK  AND  ALBERT  H. COONS 
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FIG. I0.  Effect  of  varying  the time of  CC administration on the  enhancement of  the PFC 
response.  Groups of  mice (five  animals  per  group) were given CC, at  a dose of  i mg/kg, on 
various  days (as  indicated  on  the  abscissa)  before,  during, and  after  the  immunization  with 
100/~g  of  TNP-KLH  on  day 0. Control animals  received  the same dose of  antigen but  no  CC 
was given.  14 days after  the first  injection,  all animals were challenged with 100 ~g of 
TNP-KLH. The spleens  of  the injected  animals  were harvested and assayed  for  their  TNP- 
specific  PFC response 3 days after  the second injection.  Each point represents the mean 
response _ SE of  the  CC-treated  animals (e)  or  of  the  control  animals (©).  SC, spleen  cells. 
The  timing  of the  injection  of CC  seems  to  be  critical.  For  the  maximal 
enhancing  effect, the drug has to be administered  simultaneously with or on 
the same day as the antigen  (Fig.  10). Only minimal enhancement of the PFC 
response was observed when CC was given 1 day before the injection of antigen. 
Effective enhancement had been reported in the guinea pig when CC was given 
as early as 6 h before antigen injection (9). On the other hand, administration of 
the drug 1 or 2 days after immunization was ineffective (Fig.  10). CC was also 
found to be incapable of enhancing the antibody response in rabbits when it was 
given 2 days before or 2 days after the injection of antigen (2). The failure of CC 1224  ENHANCEMENT  OF  THE  ANTIBODY  RESPONSE  BY  COLCHICINE 
TABLE I 
Enhancement of the Primary Hapten-Specific PFC Response by CC and VB 
Group 
Day 0  Day 6 
Num- 
ber  TNP-specific IgM PFC 
of mice  Treatment 
Per 106 SC  P*  Per spleen  P 
Mean +- SE 
I  12  TKB*  125 ± 30  19,500 ± 3,010 
II  11  TKB + CC§  263 ± 74  <0.001  39,420 ± 6,630  <0.002 
III  12  TKB + VBII  248 ± 57  <0.002  38,290 ± 5,850  <0.002 
*  P values in comparison to group I. 
i00 ~g TKB injected  i.p. 
§ CC administered at 1 mg/kg body weight, i.p. 
II  VB sulfate  administered at 1 mg/kg body weight, i.p. 
SC, spleen cells. 
TABLE II 
Effect of CC and LCC on the Primary Hapten-Specific PFC Response 
Day 0  Day 6 
Num- 
Group  ber  TNP-specific IgM PFC 
of mice  Treatment 
Per 106 SC  P*  Per spleen  P 
Mean +- SE 
I  6  TKB$  170 ± 28  28,700 ± 5,090 
II  6  TKB + CC§  370 -+ 32  <0.002  64,820 + 6,950 
III  6  TKB + LCCII  160 -+ 41  n.s.  29,640 ± 7,910 
<0.003 
n.s. 
* P values in comparison to group I. 
* 100 ~g TKB injected i.p. 
§ CC administered at 1 mg]kg body weight, i.p. 
II LCC administered  at 1 mg/kg body weight, i.p. 
n.s., not significant; SC, spleen cells. 
to enhance the antibody response when it was administered as early as  1 day 
after  immunization  suggests  that  certain  critical  regulatory  cellular  events 
must have taken place within 24 h  after contact with antigen. Indeed, Eardley 
and  Sercarz  (23,  24)  recently  demonstrated  in  their  elegant  studies  that 
regulatory  suppressor  cells  appeared  as  early  as  24  h  after  priming  with 
antigen, and that cell divisions were required for the expression of suppressive 
activities.  Taken together, these observations strongly support our hypothesis 
that CC may act on the early dividing suppressor cell or its precursors. 
The route of CC administration does not seem to be important. In this study, 
we injected CC and the antigen separately into the peritoneal cavity. However, 
effective enhancement had also been observed when CC and the antigen were 
injected via different routes.  For example, CC had been administered subcuta- 
neously  to  rabbits  immunized  in  the  foot-pad  (2),  and  intraporitoneally  to 
hamsters immunized intravenously (21,  22);  in both cases,  antibody formation 
was increased. PANG  N.  SHEK  AND  ALBERT  H.  COONS  1225 
If the enhancement of the antibody response by CC is dependent on the anti- 
mitotic action of the drug, then any anti-mitotic drug, e.g. VB, should also be 
capable of mediating the enhancement. Indeed, when VB was given to animals 
at the time of  antigen injection, it was found to be as effective as CC in elevating 
the antibody response (Table I). 
These observations with both CC  and VB strongly suggest that there is a 
connection between the anti-mitotic action of the drug and its enhancement of 
antibody formation. The dose of CC (1-1.5 mg/kg) that we used to enhance the 
antibody response has been shown to be effective in inhibiting mitosis in vivo 
(25, 26). If the mitosis-blocking property is crucial for the enhancing effect of 
CC,  deprivation of its  anti-mitotic capacity should render it  inactive in this 
regard. Indeed, we were able to show that the conversion of CC to its non-anti- 
mitotic structural isomer, LCC, abolished the enhancing effect (Table II). Thus, 
it seems justifiable to say that the anti-mitotic action of CC  is  an essential 
element for  successful enhancement of the  antibody  response.  The  critical 
timing in  the  administration of CC  necessary for effective enhancement, a 
feature of the effect of X-irradiation, indicates that these agents are most likely 
acting upon rapidly dividing cells.  It is noteworthy that X-irradiation which 
also  predominantly causes  damage to  dividing cells  (27) also  enhances the 
antibody response in vivo (28). 
In  contrast  to  the  enhancing  effect  reported  here,  the  mitosis-blocking 
capacity of CC has been employed to suppress the antibody response in rats by 
the  administration of the  drug a  few days after immunization,  but  within 
several hours before the treated animals were sacrificed for the PFC assay (26). 
The effective suppressing dose (1.3 mg/kg) of CC used lies within our enhancing 
dose range (1.0-1.5 mg/kg). Thus, approximately the same dose of CC adminis- 
tered to animals may mediate either enhancement or suppression of antibody 
formation depending upon the timing of drug administration in relation to the 
injection of antigen. The suppressive effect of CC, observed when the drug is 
injected in the later phase of the antibody response, has been suggested to be 
the  result  of the  mitotic blocking action  of CC  on  cellular divisions of the 
antibody-forming cell and its precursors (26). On the other hand, we postulate 
that the enhancing effect of CC, observed when it is injected at the same time 
as antigen, is the consequence of its interruption of mitosis that prevents the 
generation of antigen-stimulated, early dividing suppressor cells. 
It is clear, from the general effect of such anti-mitotic agents in rabbits, mice, 
guinea  pigs,  and  hamsters  on  both  the  primary  and  secondary  antibody 
responses to several protein antigens, that the early development of suppressor 
cells usually, if not always, accompanies antigenic stimulation. The accompa- 
nying paper presents evidence that CC does indeed prevent the development of 
suppressor cells. 
Summary 
Colchicine (CC) enhances the antibody response in mice to protein antigens, 
like diphtheria toxoid and human gamma globulin,  as well as to the 2,4,6- 
trinitrophenyl hapten.  Maximal  enhancement was  observed  when  CC  was 
administered to  animals on the  same day as  the  injection of antigen.  The 1226  ENHANCEMENT  OF  THE  ANTIBODY  RESPONSE  BY  COLCHICINE 
optimal  dose  of CC  was  in  the  range  of  1.0-1.5  mg/kg  body  weight.  The 
enhanced antibody formation was evident from elevated circulating antibody 
titers and from an increased number of antibody plaque-forming cells (PFC) of 
the  spleen.  The circulating antibody titer of CC-treated animals  was  higher 
than that of control animals by a  factor of about 3-7 in the primary response, 
and by a factor of at least 15 in the secondary response. In terms of the number 
of antibody forming cells, CC enhanced the primary PFC response by ~100%, 
and the secondary PFC response by as high as fivefold. The enhancing effect of 
CC seemed to be related to its mitosis-blocking capacity since (a) vinblastine, 
another antimitotic drug, was found to be as effective as CC and (b) lumicolchi- 
cine, the non-anti-mitotic structural isomer of CC, was ineffective in potentiat- 
ing antibody responses. The critical timing in the administration of CC on the 
same day as antigen suggests that most likely, the mitotic poison was acting on 
antigen-stimulated early dividing suppressor cells. 
The authors wish to thank Daniel Cargill for his excellent technical assistance. 
Received for publication 28 October 1977. 
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